Abstract

In April 2022, an additional medical fee for exercise instruction during haemodialysis treatment was approved for insurance claims in Japan. We conducted a questionnaire survey to investigate the current situation regarding exercise therapy during haemodialysis treatment after this change. Questionnaires were mailed to 4257 haemodialysis facilities, almost all the haemodialysis facilities in Japan, on January 31, 2023. In total, 1657 facilities responded, of which 550 (33%) provided exercise instruction during haemodialysis treatment, and 65% of these claimed the new fee. Of the 550 facilities that had claimed the fee at the time of survey, 245 (55%) started exercise instruction in April 2022 or later. Exercise instruction focused on resistance training (81%) and aerobic exercise (62%) for 20–30 min (66%) three times a week (80%). The instructors included physicians in 45% of facilities, nurses in 74%, and physical therapists in 36%. Efficacy was evaluated in 76% of the facilities providing instruction, mainly by assessing change in muscle strength (49%). Overall, 39% of facilities had experienced some adverse events, but none were life-threatening. In conclusion, after the change in the insurance regime, exercise instruction during haemodialysis treatment has become more popular, and more patients on haemodialysis are undergoing exercise therapy.

Details

Title
Exercise instruction during haemodialysis treatment after changes to the insurance regime: a nationwide questionnaire survey in Japan
Author
Sofue, Tadashi 1 ; Matsuzawa, Ryota 2 ; Nishiwaki, Hiroki 3 ; Tsuchida, Yohei 4 ; Kosaki, Keisei 5 ; Hoshino, Junichi 6 ; Narita, Ichiei 7 ; Yamagata, Kunihiro 8 

 Kagawa University, Department of Cardiorenal and Cerebrovascular Medicine, Kida-Gun, Japan (GRID:grid.258331.e) (ISNI:0000 0000 8662 309X) 
 Hyogo Medical University, Department of Physical Therapy, School of Rehabilitation, Kobe, Japan (GRID:grid.272264.7) (ISNI:0000 0000 9142 153X) 
 Showa University Fujigaoka Hospital, Division of Nephrology, Department of Internal Medicine, Yokohama, Japan (GRID:grid.412808.7) (ISNI:0000 0004 1764 9041) 
 Shinrakuen Hospital, Department of Nephrology, Niigata, Japan (GRID:grid.415782.d) (ISNI:0000 0001 0091 3414) 
 University of Tsukuba, Institute of Health and Sport Sciences, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728) 
 Tokyo Women’s Medical University, Department of Nephrology, Tokyo, Japan (GRID:grid.410818.4) (ISNI:0000 0001 0720 6587) 
 Niigata University Graduate School of Medical and Dental Sciences, Division of Clinical Nephrology and Rheumatology, Niigata, Japan (GRID:grid.260975.f) (ISNI:0000 0001 0671 5144) 
 University of Tsukuba, Department of Nephrology, Faculty of Medicine, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728) 
Pages
9171
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3043541345
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.